Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,342 | 1,694 | 506 | 1,035 | 245 |
| Cost of Goods | 815 | 1,084 | 391 | 122 | 124 |
| Gross Profit | 527 | 610 | 115 | 913 | 121 |
| Operating Expenses | 4,751 | 4,200 | 3,294 | 3,608 | 2,690 |
| Operating Income | -4,224 | -3,590 | -3,179 | -2,695 | -2,570 |
| Interest Expense | 122 | 142 | 90 | 91 | 121 |
| Other Income | 500 | 2,772 | 8 | 0 | 141 |
| Pre-tax Income | -3,846 | -960 | -3,261 | -2,786 | -2,549 |
| Net Income Continuous | -3,846 | -960 | -3,261 | -2,786 | -2,549 |
| Minority Interests | 129 | N/A | N/A | N/A | N/A |
| Net Income | $-3,717 | $-960 | $-3,261 | $-2,786 | $-2,549 |
| EPS Basic Total Ops | -0.03 | -0.01 | -0.04 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | -0.04 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.03 | -0.01 | -0.04 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.03 | -0.01 | -0.04 | -0.05 | -0.05 |
| EBITDA(a) | $-3,646 | $-764 | $-3,099 | $-2,626 | $-2,379 |